Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Conformis Inc. CFMS

Conformis Inc is an us-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.

Recent & Breaking News (NDAQ:CFMS)

ConforMIS, Inc. Announces Election of Philip W. Johnston to its Board of Directors

GlobeNewswire March 31, 2017

Mid-Afternoon Market Update: NetEase Rises On Upbeat Earnings; Avon Products Shares Plunge  February 16, 2017

22 Biggest Mid-Day Losers For Thursday  February 16, 2017

Mid-Morning Market Update: Markets Mostly Higher; Wendys Posts Mixed Q4 Report  February 16, 2017

25 Stocks Moving In Thursday's Pre-Market Session  February 16, 2017

ConforMIS Reports Fourth Quarter and the Year Ended 2016 Financial Results; Provides 2017 Financial Guidance

GlobeNewswire February 15, 2017

ConforMIS to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call and Webcast on February 15, 2017

GlobeNewswire January 17, 2017

ConforMIS Secures Up to $50 Million in Financing from Oxford Finance and Files Shelf Registration Statement

GlobeNewswire January 9, 2017

Mid-Afternoon Market Update: NeoPhotonics Drops After Disappointing Q3 Results; Bristow Shares Spike Higher  November 4, 2016

Mid-Day Market Update: ConforMIS Gains Following Strong Q3 Results; MDC Partners Shares Drop  November 4, 2016

ConforMIS Reports Third Quarter 2016 Financial Results

GlobeNewswire November 3, 2016

ConforMIS Names Industry Veteran Mark Augusti President and Chief Executive Officer

GlobeNewswire October 24, 2016

ConforMIS to Host Third Quarter 2016 Financial Results Conference Call and Webcast on November 3, 2016

GlobeNewswire October 20, 2016

ConforMIS Announces Publication of Clinical Study Demonstrating iTotal CR Customized Implants Better Approximate Normal Knee Motion When Compared to a Leading Off-the-Shelf Total Knee Implant

GlobeNewswire October 17, 2016

ConforMIS Announces Sale of Over 50,000 Customized Knee Implants

GlobeNewswire October 4, 2016

Clinical Studies Demonstrate ConforMIS iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings

GlobeNewswire August 15, 2016

ConforMIS Reports Second Quarter 2016 Financial Results and Updates Fiscal Year 2016 Revenue Guidance

GlobeNewswire August 8, 2016

ConforMIS to Host Second Quarter 2016 Financial Results Conference Call and Webcast on August 8, 2016

GlobeNewswire July 20, 2016

Study Finds High Satisfaction Amongst Patients with ConforMIS Customized Total Knee Replacements

GlobeNewswire July 6, 2016

Healthcare Sector Equities Under Review - Nanosphere, SciClone Pharma, ConforMIS, and Momenta Pharma

PR Newswire June 30, 2016